These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 14724780

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W, Majkowska L, Stefański A, Moleda P.
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [Abstract] [Full Text] [Related]

  • 3. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 4. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A, Spannheimer A, Reitberger U, Görtz A.
    Med Klin (Munich); 2002 Dec 15; 97(12):713-9. PubMed ID: 12491064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S, Schramm W, Schneider B, Neeser K, Weber C, Lodwig V, Heinemann L, Scherbaum WA, Kolb H.
    Exp Clin Endocrinol Diabetes; 2007 Sep 15; 115(8):495-501. PubMed ID: 17853332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB.
    Gesundheitswesen; 2006 Oct 15; 68(10):600-12. PubMed ID: 17099820
    [Abstract] [Full Text] [Related]

  • 10. Feature selection and classification model construction on type 2 diabetic patients' data.
    Huang Y, McCullagh P, Black N, Harper R.
    Artif Intell Med; 2007 Nov 15; 41(3):251-62. PubMed ID: 17707617
    [Abstract] [Full Text] [Related]

  • 11. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M, Nawaf G, Nawaf F, Itzhak B, Minuchin O, Vardi P.
    Isr Med Assoc J; 2006 Jun 15; 8(6):378-82. PubMed ID: 16833164
    [Abstract] [Full Text] [Related]

  • 12. An algorithm for the treatment of type 2 diabetes in Latin America.
    Chacra AR, Davidson JA, Diaz J, Escalante-Pulido M, Litwak LE, Mestman JH, More L, Violante RM.
    Diabetes Obes Metab; 2005 Mar 15; 7(2):148-60. PubMed ID: 15715888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A cost of illness study of diabetes mellitus].
    von Ferber L, Köster I, Hauner H.
    Gesundheitswesen; 1997 Jan 15; 59(1):17-22. PubMed ID: 9138642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.